2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati (scientific article published on 29 August 2015)

cites work (P2860)

Q37399211	"One-Time" versus Staged Multivessel Intervention in Intermediate to Very High-Risk Patients with Non-ST-Segment Elevation Acute Coronary Syndromes
Q59138200	"Ultra-sensitive" cardiac troponins: Requirements for effective implementation in clinical practice
Q47620332	0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction
Q37647504	2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group
Q57057499	2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Q50065204	2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
Q57621041	2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Q50089557	2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.
Q96138617	31 days of COVID-19-cardiac events during restriction of public life-a comparative study
Q38788267	A 0-Hour/1-Hour Protocol for Safe, Early Discharge of Chest Pain Patients.
Q93047002	A Case of Acute Coronary Occlusion in a Morbidly Obese Patient Masked on Electrocardiogram by Low QRS Voltage
Q38669533	A Novel Risk Scoring System to Predict Cardiovascular Death in Patients With Acute Myocardial Infarction: CHA2DS2-VASc-CF Score.
Q93089183	A Propensity Score Matching Analysis of Transradial Versus Transfemoral Approaches in Octogenarians Undergoing Percutaneous Coronary Intervention
Q47570792	A Prospective, Randomized, Open-Label, Blinded, Endpoint Study Exploring Platelet Response to Half-Dose Prasugrel and Ticagrelor in Patients with the Acute Coronary Syndrome: HOPE-TAILOR Study
Q33735504	A Rational Adoption of the High Sensitive Assay for Cardiac Troponin I in Diagnostic Routine.
Q47575001	A Risk Assessment Score and Initial High-sensitivity Troponin Combine to Identify Low Risk of Acute Myocardial Infarction in the Emergency Department
Q38672923	A Safety Evaluation of Cangrelor in Patients Undergoing PCI.
Q90577536	A Score to differentiate Takotsubo syndrome from non-ST-elevation myocardial nfarction in women at the bedside
Q64882378	A brief review on resistance to P2Y12 receptor antagonism in coronary artery disease.
Q61795744	A call for action in bleeding prevention
Q90599795	A case report of a recurrent early and late Bioresorbable vascular scaffold thrombosis: serial angiography and optical coherence tomography findings
Q93086040	A comprehensive validation of very early rule-out strategies for non-ST-segment elevation myocardial infarction in emergency departments: protocol for a multicentre prospective cohort study
Q50547169	A consensus statement on lipid management after acute coronary syndrome.
Q55379764	A critical electrocardiographic pattern in the age of cardiac biomarkers.
Q50085836	A fully integrated microfluidic platform for highly sensitive analysis of immunochemical parameters
Q60045608	A multicentre, randomized, controlled open-label trial to compare an Accelerated Rule-Out protocol using combined prehospital copeptin and in-hospital high sensitive troponin with standard rule-out in patients suspected of acute Myocardial Infarction
Q90026935	A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography
Q48510946	A novel troponin I rule-out value below the upper reference limit for acute myocardial infarction
Q61450633	A phase 1, first-in-human study of F-GP1 positron emission tomography for imaging acute arterial thrombosis
Q90554208	A predictive value of the dynamic changes of the P-wave terminal force in lead V1 in the long-term prognosis of patients with non-ST-segment elevation acute coronary syndrome
Q64243680	A prescription support-tool for chronic management of oral antithrombotic combinations in adults based on a systematic review of international guidelines
Q92858734	A prospective cohort study of self-reported computerised medical history taking for acute chest pain: protocol of the CLEOS-Chest Pain Danderyd Study (CLEOS-CPDS)
Q90148246	A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation
Q39012459	A review of Rapid Access Cardiology services - Can these reduce the burden of acute chest pain on Australian and New Zealand health services?
Q52650262	A score for decision making during percutaneous coronary intervention in acute myocardial infarction patients with multivessel disease.
Q47377283	A single centre prospective cohort study addressing the effect of a rule-in/rule-out troponin algorithm on routine clinical practice.
Q89919293	A systematic review and meta-analysis on the effectiveness of an invasive strategy compared to a conservative approach in patients > 65 years old with non-ST elevation acute coronary syndrome
Q47111055	ACTION (acute coronary treatment and intervention outcomes network) registry-GWTG (get with the guidelines) risk score predicts long-term mortality in acute myocardial infarction
Q41118450	ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes
Q41083032	ANMCO-SIMEU Consensus Document: in-hospital management of patients presenting with chest pain
Q33647497	ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy
Q40490419	ANMCO/SIT Consensus Document: telemedicine for cardiovascular emergency networks
Q38849090	Access to medicines and diagnostic tests integral in the management of diabetes mellitus and cardiovascular diseases in Uganda: insights from the ACCODAD study
Q89807715	Access-Site Complications in Mechanical Thrombectomy for Acute Ischemic Stroke: A Review of Prospective Trials
Q90219800	Acute Coronary Syndrome Mimicking Takotsubo Cardiomyopathy or Takotsubo Cardiomyopathy Mimicking Acute Coronary Syndrome?
Q90393639	Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics
Q55002696	Acute Heart Failure Management.
Q55440299	Acute Kidney Injury in Diabetic Patients With Acute Myocardial Infarction: Role of Acute and Chronic Glycemia.
Q26746199	Acute chest pain in the high-sensitivity cardiac troponin era: A changing role for noninvasive imaging?
Q51337029	Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004-14.
Q88960063	Acute coronary syndromes
Q57176231	Acute coronary syndromes diagnosis, version 2.0: Tomorrow's approach to diagnosing acute coronary syndromes?
Q61805882	Acute kidney injury in patients with myocardial infarction undergoing percutaneous coronary intervention using radial versus femoral access
Q48368949	Acute kidney injury requiring dialysis and in-hospital mortality in patients with chronic kidney disease and non-ST-segment elevation acute coronary syndrome undergoing early vs delayed percutaneous coronary intervention: A nationwide analysis
Q50101365	Acute myocardial infarction in patients with ST-segment elevation myocardial infarction : ESC guidelines 2017
Q47140577	Acute stent thrombosis after stent-assisted coiling in an intracranial aneurysm patient carrying two reduced-function CYP2C19 alleles: A case report
Q30241848	Adaptive Immunity Dysregulation in Acute Coronary Syndromes: From Cellular and Molecular Basis to Clinical Implications
Q36007741	Adherence to Cardiac Practice Guidelines in the Management of Non-ST-Elevation Acute Coronary Syndromes: A Systematic Literature Review
Q92024563	Adherence to guideline recommendations for coronary angiography in a poor South-East Asian setting: Impact on short- and medium-term clinical outcomes
Q41389822	Adiponectin and T-Cadherin: a Tree for Biomarkers in ST-Elevation or Non-ST-Elevation Myocardial Infarction
Q39254947	Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospective review.
Q55021882	Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain.
Q38600330	Advanced Percutaneous Mechanical Circulatory Support Devices for Cardiogenic Shock
Q33890811	Advances in Clinical Cardiology 2016: A Summary of the Key Clinical Trials
Q46256261	Age and gender differences in medical adherence after myocardial infarction: Women do not receive optimal treatment - The Netherlands claims database
Q59794225	All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with tr
Q40638471	An algorithm for rule-in and rule-out of acute myocardial infarction using a novel troponin I assay.
Q38813299	An update on management of the patient presenting with non-ST-elevation acute coronary syndromes
Q37844001	Analysis of clinical phenomena and changes in physico-chemical properties of the blood in mentally ill children
Q42334342	Anemia and Acute Coronary Syndrome: Time for Intervention Studies
Q90055273	Anemia in patients with high-risk acute coronary syndromes admitted to Intensive Cardiac Care Units
Q47281220	Anesthetic ointment only (lidocaine/prilocaine) instead of injectable local lidocaine in trans-radial catheterization: A viable no-needle alternative
Q41104013	Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction
Q90198953	Animation-supported consent for urgent angiography and angioplasty: a service improvement initiative
Q40450719	Anti-glioma action of aloe emodin: the role of ERK inhibition.
Q89177868	Anticoagulant Therapy for Acute Coronary Syndromes
Q90055787	Anticoagulant and antiplatelet combined therapy in patients 75 years and over with atrial fibrillation: a prospective observational study assessing adherence to clinical guidelines
Q47984703	Anticoagulation after coronary stenting: a systemic review
Q61454254	Anticoagulation in Patients with Ischaemic Heart Disease and Peripheral Arterial Disease: Clinical Implications of COMPASS Study
Q92128593	Anticoagulation in chronic kidney disease: from guidelines to clinical practice
Q38762278	Anticoagulation in coronary intervention
Q50044401	Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns an
Q50864337	Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex "Real" Clinical Scenarios: A Consensus Document of the "Campania NSTEMI Study Group".
Q93379484	Antiplatelet agents in uncertain clinical scenarios-a bleeding nightmare
Q57689029	Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies
Q94327168	Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies
Q48761201	Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease
Q42376424	Antiplatelet drug ticagrelor delays gastric ulcer healing in rats
Q64277113	Antiplatelet therapy in very elderly and comorbid patients with acute coronary syndromes
Q42350175	Antiplatelet therapy with CABG: chaos in the Netherlands
Q91886489	Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry
Q59795416	Antithrombotic Regimens in Patients With Percutaneous Coronary Intervention Whom an Anticoagulant Is Indicated: A Systematic Review and Network Meta-Analysis
Q47632915	Antithrombotic Therapy for ACS in Elderly Patients
Q38742687	Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis
Q28072522	Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation
Q39295736	Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention
Q50068546	Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention
Q39147735	Antithrombotic therapy for patients with STEMI undergoing primary PCI.
Q38917775	Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease
Q39329927	Antithrombotic therapy in end-stage renal disease.
Q45028902	Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes
Q52804575	Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
Q41265453	Antithrombotic treatment tailoring and risk score evaluation in elderly patients diagnosed with an acute coronary syndrome.
Q55283899	Application of Feedback System Control Optimization Technique in Combined Use of Dual Antiplatelet Therapy and Herbal Medicines.
Q91605535	Application of Risks Scores in Acute Coronary Syndromes. How Does ProACS Hold Up Against Other Risks Scores?
Q47169221	Applied mediation analyses: a review and tutorial
Q38876279	Appropriate pathology ordering? Troponin testing within an Australian Emergency Department.
Q60914240	Artificial intelligence to predict needs for urgent revascularization from 12-leads electrocardiography in emergency patients
Q33555770	Asia-Pacific consensus statement on the optimal use of high-sensitivity troponin assays in acute coronary syndromes diagnosis: focus on hs-TnI.
Q64972193	Aspirin Use and Cardiovascular Outcome in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Population-Based Cohort Study.
Q48338773	Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk
Q57475615	Assessing Performance and Quality After Non-ST Segment Elevation Acute Coronary Syndromes
Q92501280	Assessing Prognosis of Acute Coronary Syndrome in Recent Clinical Trials: A Systematic Review
Q28078265	Assessment and classification of patients with myocardial injury and infarction in clinical practice
Q90737896	Assessment of Equity in Access to Percutaneous Coronary Intervention (PCI) Centres in Poland
Q90020242	Assessment of the Risk of Rhabdomyolysis and Myopathy During Concomitant Treatment with Ticagrelor and Statins
Q96137355	Association between Adherence to Guideline-Recommended Preventive Medications and In-Hospital Mortality among Non-Reperfused ST-Elevation Myocardial Infarction Patients Admitted to a Tertiary Care Academic Center in a Developing Country
Q42376761	Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study
Q91844971	Association between inflammatory cytokines and long-term adverse outcomes in acute coronary syndromes: A systematic review
Q58088762	Association between left atrial strain and left ventricular diastolic function in patients with acute coronary syndrome
Q93137922	Association between neutrophil-lymphocyte ratio and arterial stiffness in patients with acute coronary syndrome
Q64973911	Association between post-procedural hyperoxia and poor functional outcome after mechanical thrombectomy for ischemic stroke: an observational study.
Q88674963	Association between serum S100A1 level and Global Registry of Acute Coronary Events score in patients with non-ST-segment elevation acute coronary syndrome
Q91976118	Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function
Q64241793	Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction
Q47414008	Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome
Q64239222	Association of Obstructive Sleep Apnea With Cardiovascular Outcomes in Patients With Acute Coronary Syndrome
Q64924978	Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome.
Q54597749	Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk My
Q38813385	Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative
Q41138179	Association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure.
Q59336176	Association of sleep problems with neuroendocrine hormones and coagulation factors in patients with acute myocardial infarction
Q94672599	Association of β-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart Failure
Q58739934	Associations of 26 Circulating Inflammatory and Renal Biomarkers with Near-Infrared Spectroscopy and Long-term Cardiovascular Outcome in Patients Undergoing Coronary Angiography (ATHEROREMO-NIRS Substudy)
Q88779687	Associations of sensitive cardiac troponin-I with left ventricular morphology, function and prognosis in end-stage renal disease patients with preserved ejection fraction
Q94331374	Author`s Reply
Q38884026	Avoiding non-responders to cardiac resynchronization therapy: a practical guide
Q53970208	Awareness of cardiovascular disease, its risk factors, and its association with attendance at outpatient clinics in acute coronary syndrome patients.
Q55192415	A practical guide on how to handle patients with bleeding events while on oral antithrombotic treatment.
Q53769393	Be more sensitive, please - using cardiac troponin assays for diagnosing AMI.
Q64246336	Benefit of Early Statin Initiation within 48 Hours after Admission in Statin-Naïve Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Q50641638	Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study.
Q57389407	Beta-blockers for non-acute treatment after myocardial infarction
Q57389442	Beta-blockers for suspected or diagnosed acute myocardial infarction
Q39288609	Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study
Q89338254	Biomarker in cardiology : DGK welcomes ESC Munich 2018
Q61454620	Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity
Q38664211	Biomarkers in Sleep Apnea and Heart Failure
Q54624187	Biomarkers in the triage of chest pain: are we making progress?
Q64090263	Biomarkers of Atrial Fibrillation: Which One Is a True Marker?
Q48603853	Biomarkers, lactate, and clinical scores as outcome predictors in systemic poisons exposures.
Q59138194	Biotin and high-sensitivity cardiac troponin T assay
Q92069562	Bleeding complications with clopidogrel or ticagrelor in ST-elevation myocardial infarction patients - A real life cohort study of two treatment strategies
Q55253937	Body mass index and the risk of low femoral artery puncture in coronary angiography under fluoroscopy guidance.
Q42318497	Bonsai-induced coronary artery spasm
Q94593343	Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
Q50050747	Bridging the Atlantic gap in clinical guidelines for non-ST-elevation acute coronary syndromes
Q46597636	Bridging with Tirofiban during Oral Antiplatelet Interruption: A Single-Center Case Series Analysis Including Patients on Hemodialysis
Q90291009	C-reactive protein as a predictor of malignant ventricular arrhythmias in non-ST elevation myocardial infarction
Q52567727	CHA2 DS2 -VASc score and clinical outcomes of patients with chest pain discharged from internal medicine wards following acute coronary syndrome rule-out.
Q92081837	COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Q47565719	CT Imaging of the Vulnerable Plaque
Q64924292	Calculating the 30-day Survival Rate in Acute Myocardial Infarction: Should we Use the Treatment Chain or the Hospital Catchment Model?
Q36857842	Canada acute coronary syndrome score was a stronger baseline predictor than age ≥75 years of in-hospital mortality in acute coronary syndrome patients in western Romania
Q39051460	Cancer Event Rate and Mortality with Thienopyridines: A Systematic Review and Meta-Analysis
Q59802317	Cangrelor Induces More Potent Platelet Inhibition without Increasing Bleeding in Resuscitated Patients
Q38846758	Cangrelor for the management and prevention of arterial thrombosis.
Q49926557	Cangrelor in Percutaneous Coronary Intervention: Current Status and Perspectives
Q92455983	Cardiac Magnetic Resonance Left Ventricular Mechanical Uniformity Alterations for Risk Assessment After Acute Myocardial Infarction
Q92179634	Cardiac Myosin-Binding Protein C to Diagnose Acute Myocardial Infarction in the Pre-Hospital Setting
Q64245221	Cardiac Myosin-Binding Protein C-From Bench to Improved Diagnosis of Acute Myocardial Infarction
Q90242232	Cardiac Troponin T and Troponin I in the General Population
Q58123943	Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney Disease
Q89759750	Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis
Q37670587	Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin
Q41513575	Cardiac computed tomography-derived epicardial fat volume and attenuation independently distinguish patients with and without myocardial infarction
Q50094429	Cardiac rehabilitation after percutaneous coronary intervention: Results from a nationwide survey
Q42646638	Cardiac rehabilitation in patients who underwent primary percutaneous coronary intervention for acute myocardial infarction: determinants of programme participation and completion
Q49954553	Cardiac troponins: 25 years on the stage and still improving their clinical value
Q47671109	Cardiac troponins: from myocardial infarction to chronic disease.
Q49835894	Cardiogenic shock : Current evidence
Q36411375	Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril
Q90170926	Cardioprotective medication adherence in Western Australians in the first year after myocardial infarction: restricted cubic spline analysis of adherence-outcome relationships
Q26745756	Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspnea
Q90089116	Cardiotoxicity from immune checkpoint inhibitors
Q93201345	Cardiovascular emergencies in the COVID-19 pandemic
Q61454621	Cardiovascular imaging in cardio-oncology
Q64289339	Challenges in high-sensitive troponin assay interpretation for intensive therapy
Q90377016	Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease-a review
Q30357516	Chest pain: coronary CT in the ER.
Q90640994	Choosing Clinical Variables for Risk Stratification Post-Acute Coronary Syndrome
Q38944856	Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care
Q47691394	Circadian rhythm of blood cardiac troponin T concentration.
Q91817259	Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements
Q96134884	Circulating metabolites from the choline pathway and acute coronary syndromes in a Chinese case-control study
Q64054772	Circulating miR-26a-1, miR-146a and miR-199a-1 are potential candidate biomarkers for acute myocardial infarction
Q42370383	Circulating micro ribonucleic acids in cardiovascular disease: a look beyond myocardial injury
Q60920330	Circulating microRNA-1 in the diagnosis and predicting prognosis of patients with chest pain: a prospective cohort study
Q92840428	Circulating microRNAs as potential biomarkers for unstable angina
Q93093479	Clinical Characteristics and Adverse Events in Acute Coronary Syndrome Patients with a History of Peripheral Arterial Disease
Q38805520	Clinical Perspectives and Pearls from the 2015 ESC NSTE-ACS Guidelines.
Q90040911	Clinical Significance of Elevated High-sensitivity Troponin T in Low Likelihood Acute Coronary Syndrome Patients
Q59797608	Clinical and Economic Analysis of Lipid Goal Attainments in Chinese Patients with Acute Coronary Syndrome Who Received Post-Percutaneous Coronary Intervention
Q64277025	Clinical and prognostic implications of delirium in elderly patients with non-ST-segment elevation acute coronary syndromes
Q64967638	Clinical associations of microvascular obstruction and intramyocardial hemorrhage on cardiovascular magnetic resonance in patients with acute ST segment elevation myocardial infarction (STEMI): An observational cohort study.
Q33700169	Clinical characteristics of patients with suspected cardiac chest pain and angiographically normal coronary arteries in a secondary care hospital
Q58765588	Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department
Q51736773	Clinical effects with inhibition of multiple coagulative pathways in patients admitted for acute coronary syndrome.
Q92468384	Clinical impact of using a more sensitive troponin assay in patients with acute chest pain
Q64082042	Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock
Q38656364	Clinical pathways and management of antithrombotic therapy in patients with acute coronary syndrome (ACS): a Consensus Document from the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Society of E
Q92463075	Clinical significance of obstructive sleep apnea in patients with acute coronary syndrome in relation to diabetes status
Q42330822	Clinical utility of novel biomarkers in acute myocardial infarction
Q39177907	Clinical utility of sympathetic blockade in cardiovascular disease management
Q53806749	Clopidogrel instead of prasugrel or ticagrelor after 1 month in stabilized ACS patients: back to square one for DAPT?
Q48794256	Clopidogrel reloading for patients with acute myocardial infarction already on clopidogrel therapy
Q61814486	Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
Q89220492	Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel
Q64240252	Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study
Q61796079	Combination of Platelet expression of PKCepsilon and cardiac troponin-I for early diagnosis of chest pain patients in the emergency department
Q52641565	Combined value of red blood cell distribution width and global registry of acute coronary events risk score on predicting long-term major adverse cardiac events in STEMI patients undergoing primary PCI.
Q58805896	Combining anticoagulation and antiplatelet drugs in coronary artery disease
Q92837052	Common Data Elements for Acute Coronary Syndrome: Analysis Based on the Unified Medical Language System
Q90523036	Common Vascular Toxicities of Cancer Therapies
Q92496457	Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury
Q38998154	Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome
Q90182430	Comparison between radial versus femoral percutaneous coronary intervention access in Indonesian hospitals, 2017-2018: A prospective observational study of a national registry
Q64088444	Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention
Q64251352	Comparison of 30-Day MACE between Immediate versus Staged Complete Revascularization in Acute Myocardial Infarction with Multivessel Disease, and the Effect of Coronary Lesion Complexity
Q48636205	Comparison of 4 different strategies of DAPT after PCI in ACS real world population from a Northern Italy registry
Q55378964	Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome.
Q36111420	Comparison of Electric- and Magnetic-Cardiograms Produced by Myocardial Ischemia in Models of the Human Ventricle and Torso
Q50141173	Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome.
Q90457305	Comparison of Shear Stress-Induced Thrombotic and Thrombolytic Effects Among 3 Different Antithrombotic Regimens in Patients With Acute Coronary Syndrome
Q38818086	Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study.
Q90249431	Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel
Q42375730	Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study
Q89501314	Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation
Q40075975	Comparison of radial access versus femoral access with the use of a vascular closure device for the prevention of vascular complications and mortality after percutaneous coronary intervention
Q50125830	Comparison of the AHA/ACC vs ESC guidelines for management of patients with non-ST-elevation acute coronary syndromes: Are the differences clinically different?
Q98290111	Comparison of the CAMI-NSTEMI and GRACE Risk Model for Predicting In-Hospital Mortality in Chinese Non-ST-Segment Elevation Myocardial Infarction Patients
Q33601439	Comparison of the Efficacy and Safety of Early Rule-Out Pathways for Acute Myocardial Infarction
Q33615438	Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding scores in ACS patients undergoing PCI: insights from a cohort of 4939 patients in China
Q40469720	Comparison of transradial and transfemoral access in patients undergoing percutaneous coronary intervention for complex coronary lesions.
Q92195206	Comparison of usual care and the HEART score for effectively and safely discharging patients with low-risk chest pain in the emergency department: would the score always help?
Q92380091	Concentration Determination of >200 Proteins in Dried Blood Spots for Biomarker Discovery and Validation
Q56384060	Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease
Q41082977	Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to p
Q60049583	Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines
Q92189325	Contemporary Management of Out-of-hospital Cardiac Arrest in the Cardiac Catheterisation Laboratory: Current Status and Future Directions
Q38793797	Contemporary Reflections on the Safety of Long-Term Aspirin Treatment for the Secondary Prevention of Cardiovascular Disease
Q92885367	Contemporary Revascularization Dilemmas in Older Adults
Q50497419	Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney Disease.
Q50179220	Contemporary Trends and Outcomes Associated With the Preprocedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Q48639751	Contemporary Use of Oral Antithrombotic Agents: Focus on Dual and Triple Therapeutic Approaches
Q47258097	Contemporary antiplatelet therapy in acute coronary syndromes: are there differences in outcomes and discontinuation between clopidogrel and ticagrelor?
Q50124638	Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group
Q33817357	Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry
Q92968259	Contrast induced acute kidney injury and the role of beta-blockers in its prevention
Q48088913	Controversies in complex percutaneous coronary intervention: radial versus femoral.
Q92133292	Convalescent troponin and cardiovascular death following acute coronary syndrome
Q55002418	Copeptin as a Prognostic Marker in Acute Chest Pain and Suspected Acute Coronary Syndrome.
Q91601225	Copeptin with high-sensitivity troponin at presentation is not inferior to serial troponin measurements for ruling out acute myocardial infarction
Q33718126	Coronary Aneurysm Formation After Bioresorbable Vascular Scaffold Implantation Resulting in Acute Myocardial Infarction
Q47110351	Coronary CT angiography-future directions
Q40169143	Coronary Revascularization in Cardiogenic Shock
Q48806861	Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment
Q50575232	Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study.
Q48761175	Coronary artery disease: Risk stratification and patient selection for more aggressive secondary prevention
Q93014308	Corrected QT Interval Prolongations in Patients with Non-ST-Elevation Acute Coronary Syndrome
Q90538064	Correlation between the serum procalcitonin level and the extension and severity of coronary artery disease in patients with non-ST-segment elevation myocardial infarction
Q64910328	Correlations of soluble osteoclast-associated receptor (sOSCAR) with acute coronary syndrome.
Q58715786	Cost analysis of early discharge using combined copeptin/cardiac troponin testing versus serial cardiac troponin testing in patients with suspected acute coronary syndrome
Q94583805	Covid-19: implications for prehospital, emergency and hospital care in patients with acute coronary syndromes
Q90690130	Critical appraisal of guidelines for coronary artery disease on dual antiplatelet therapy: More consensus than controversies
Q98736032	Cyclophilins in Ischemic Heart Disease: Differences Between Acute and Chronic Coronary Artery Disease Patients
Q90613054	Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes
Q57143053	De-Escalation of P2Y12 Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention
Q60949506	De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial Infarction
Q61804282	De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a narrative review
Q38830086	Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients' care
Q92554253	Defining and managing patients with non-ST-elevation myocardial infarction: Sorting through type 1 vs other types
Q39036217	Defining the Place of Ezetimibe/Atorvastatin in the Management of Hyperlipidemia
Q41696643	Derivation and Validation of Shock Index as a parameter for Predicting Long-term Prognosis in Patients with Acute Coronary Syndrome
Q49980042	Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial
Q93145026	Design and rationale for the "Me & My Heart" (eMocial) study: A randomized evaluation of a new smartphone-based support tool to increase therapy adherence of patients with acute coronary syndrome
Q37728413	Design and reliability of a specific instrument to evaluate patient safety for patients with acute myocardial infarction treated in a predefined care track: a retrospective patient record review study in a single tertiary hospital in the Netherlands
Q93024451	Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial
Q64118507	Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor
Q41265481	Determinants of invasive strategy in elderly patients with non-ST elevation myocardial infarction
Q92659062	Determination of high-sensitivity cardiac troponin T upper reference limits under the improved selection criteria in a Chinese population
Q64101522	Development and Validation of a Novel Risk Score for In-Hospital Major Bleeding in Acute Myocardial Infarction:-The SWEDEHEART Score
Q64974187	Development of New Antithrombotic Regimens for Patients with Acute Coronary Syndrome.
Q38670596	Diabetes: Prevalence, prognosis and management of a potent cardiovascular risk factor.
Q40056417	Diagnosis of Acute Coronary Syndrome with a Support Vector Machine.
Q90111668	Diagnosis of myocardial infarction at autopsy: AECVP reappraisal in the light of the current clinical classification
Q64099646	Diagnostic accuracy of contemporary and high-sensitivity cardiac troponin assays used in serial testing, versus single-sample testing as a comparator, to triage patients suspected of acute non-ST-segment elevation myocardial infarction: a systematic
Q26746722	Diagnostic algorithms for acute coronary syndrome-is one better than another?
Q47286819	Diagnostic and prognostic role of resistin and copeptin in acute ischemic stroke
Q52687502	Diagnostic value of the cardiac electrical biomarker, a novel ECG marker indicating myocardial injury, in patients with symptoms suggestive of non-ST-elevation myocardial infarction.
Q61804719	Differences in pain treatment between surgeons and anaesthesiologists in a physician staffed prehospital emergency medical service: a retrospective cohort analysis
Q47665315	Differences in relative and absolute effectiveness of oral P2Y 12 inhibition in men and women: a meta-analysis and modelling study
Q58594983	Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life
Q92816550	Differential Effects of Ticagrelor With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers
Q41191967	Differential Impact of Hyperglycemia in Critically Ill Patients: Significance in Acute Myocardial Infarction but Not in Sepsis?
Q47275584	Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.
Q50126817	Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis.
Q47613575	Discrimination of patients with type 2 myocardial infarction
Q91744178	Distal Radial Artery Access: The Future of Cardiovascular Intervention
Q55365723	Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?
Q38714589	Does cardiac rhythm monitoring in patients with elevated troponin levels lead to changes in management?
Q37597744	Does heart rate variability correlate with long-term prognosis in myocardial infarction patients treated by early revascularization?
Q58128817	Does the use of rotational atherectomy procedure during percutaneous coronary interventions influence the frequency of procedure-related myocardial injury assessed by cardiac magnetic resonance?
Q57389444	Drug-eluting stents versus bare-metal stents for acute coronary syndrome
Q38612419	Drug-eluting stents versus bare-metal stents for acute coronary syndrome.
Q57389445	Drug-eluting stents versus bare-metal stents for stable ischaemic heart disease
Q61401127	Dual Antiplatelet Therapy After Drug-eluting Stent Implantation
Q38866836	Dual antiplatelet therapy after coronary stenting
Q52813379	Dual antiplatelet therapy after percutaneous coronary intervention for stable CAD or ACS : Redefining the optimal duration of treatment.
Q38676856	Dual antiplatelet therapy duration in patients following percutaneous coronary intervention or after acute coronary syndrome: one size does not fit all.
Q42650020	Dual antiplatelet therapy for secondary prevention of coronary artery disease.
Q47691417	Duration of antiplatelet therapy after DES implantation: can we trust non-inferiority open-label trials?
Q48748333	Duration of dual anti-platelet therapy - State of the art after the DAPT and PEGASUS-TIMI 54 trials
Q38751834	Duration of dual antiplatelet therapy in acute coronary syndrome
Q33846316	Dynamic high-sensitivity troponin elevations in atrial fibrillation patients might not be associated with significant coronary artery disease.
Q58699121	Dynamics of high-sensitivity cardiac troponin T during therapy with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Q64069812	Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up
Q64251260	ECG Imaging to Detect the Site of Ventricular Ischemia Using Torso Electrodes: A Computational Study
Q52795561	ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
Q91875337	Early Clinical Outcomes of Surgical Myocardial Revascularization for Acute Coronary Syndromes Complicated by Cardiogenic Shock: A Report From the North-Rhine-Westphalia Surgical Myocardial Infarction Registry
Q36110169	Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of Stay
Q38896245	Early Invasive Strategy and In-Hospital Survival Among Diabetics With Non-ST-Elevation Acute Coronary Syndromes: A Contemporary National Insight.
Q92157182	Early Recovery of Left Ventricular Function After Revascularization in Acute Coronary Syndrome
Q55421028	Early and Chronic Dipeptidyl-Peptidase-IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial.
Q61805775	Early and comprehensive care bundle in the elderly for acute heart failure in the emergency department: study protocol of the ELISABETH stepped-wedge cluster randomized trial
Q47651343	Early diagnosis of acute coronary syndrome
Q50217429	Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin
Q36319844	Early diagnosis of acute myocardial infarction using high-sensitivity troponin I
Q40605054	Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the ELISA-3 trial
Q48536704	Early prognosis and predictor analysis for positive coronary angiography after out-of-hospital cardiac arrest (OHCA).
Q90329680	Early treatment with high-potency statins in patients with acute coronary syndrome-an example of personalized medicine
Q48198112	Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial.
Q45443523	Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department.
Q38843659	Editor's Choice-Biomarkers of acute cardiovascular and pulmonary diseases
Q52851538	Editor's Choice-Rule-in of acute myocardial infarction: Focus on troponin.
Q40238674	Editor's Choice-The organization of chest pain units: Position statement of the Acute Cardiovascular Care Association.
Q94062332	Educating non-cardiologists improves the initial management of patients with non-ST elevated myocardial infarction
Q64891232	Education of Migrant and Nonmigrant Patients Is Associated With Initiation and Discontinuation of Preventive Medications for Acute Coronary Syndrome.
Q50027852	Effect and Safety of Morphine Use in Acute Anterior ST-Segment Elevation Myocardial Infarction
Q41377223	Effect of Dialysis on Antiplatelet Drug Efficacy in Uremic Patients with Coronary Heart Disease
Q89846940	Effect of Hyperoxia on Myocardial Oxygenation and Function in Patients With Stable Multivessel Coronary Artery Disease
Q60950476	Effect of Potent P2Y Inhibitors on Ventricular Arrhythmias and Cardiac Dysfunction in Coronary Artery Disease: A Systematic Review and Meta-Analysis
Q92126284	Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
Q61821140	Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis
Q42376860	Effect of weekend admission on process of care and clinical outcomes for the management of acute coronary syndromes: a retrospective analysis of three UK centres
Q92133412	Effective combination of isolated symptom variables to help stratifying acute undifferentiated chest pain in the emergency department
Q90202786	Effectiveness and safety of oral Chinese patent medicines as adjuvant treatment for unstable angina pectoris on the national essential drugs list of China: a protocol for a systematic review and network meta-analysis
Q33876773	Effects of aerobic exercise on lipids and lipoproteins
Q39366233	Effects of autologous platelet transfusion on platelet inhibition in ticagrelor-treated and clopidogrel-treated subjects
Q30836980	Effects of cardiac telerehabilitation in patients with coronary artery disease using a personalised patient-centred web application: protocol for the SmartCare-CAD randomised controlled trial
Q48204482	Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study
Q47792745	Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome.
Q47286408	Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry
Q89733603	Efficacy and Safety of High Potent P2Y12 Inhibitors Prasugrel and Ticagrelor in Patients With Coronary Heart Disease Treated With Dual Antiplatelet Therapy: A Sex-Specific Systematic Review and Meta-Analysis
Q90188086	Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions
Q88356487	Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials
Q53581195	Efficacy and safety of prolonged dual antiplatelet therapy: a meta-analysis of 15 randomized trials enrolling 85 265 patients.
Q64277061	Elderly patients with acute coronary syndromes: a continuous tsunami
Q64074167	Elevated High-Sensitivity Troponin I in the Stabilized Phase after an Acute Coronary Syndrome Predicts All-Cause and Cardiovascular Mortality in a Highly Admixed Population: A 7-Year Cohort
Q36476201	Elevated high-sensitive troponin T on admission is an indicator of poor long-term outcome in patients with subarachnoid haemorrhage: a prospective observational study
Q45789037	Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction
Q47613511	Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes
Q88313231	Emergency ultrasound and echocardiography in patients with infarct-related cardiogenic shock : A survey among members of the German Society of Medical Intensive Care and Emergency Medicine
Q36068352	Emerging roles of thioredoxin cycle enzymes in the central nervous system
Q48510552	Eminence, common sense, and evidence: a comment to the Andreas Grüntzig lecture 2015.
Q92321074	Endocannabinoid 2-arachidonoylglycerol is elevated in the coronary circulation during acute coronary syndrome
Q90156869	Enhance the effectiveness of clinical laboratory critical values initiative notification by implementing a closed-loop system: A five-year retrospective observational study
Q48257908	Enhancing prescribing of guideline-recommended medications for ischaemic heart diseases: a systematic review and meta-analysis of interventions targeted at healthcare professionals.
Q36086607	Environmental stressors and cardio-metabolic disease: part I-epidemiologic evidence supporting a role for noise and air pollution and effects of mitigation strategies
Q39350236	Epicardial potentials computed from the body surface potential map using inverse electrocardiography and an individualised torso model improve sensitivity for acute myocardial infarction diagnosis
Q91609353	Ergonovine Stress Echocardiography for the Diagnosis of Vasospastic Angina and Its Prognostic Implications in 3,094 Consecutive Patients
Q42033437	Establishment of a hybrid risk model to predict major cardiac adverse events in patients with non-ST-elevation acute coronary syndromes
Q61670793	European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection
Q52845873	European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk.
Q64967537	European survey on preanalytical sample handling - Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (E
Q49444590	Evaluation and management of patients with acute chest pain in China (EMPACT): protocol for a prospective, multicentre registry study
Q92509120	Evaluation of Molecularly Imprinted Polymers for Point-of-Care Testing for Cardiovascular Disease
Q55024763	Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia.
Q91838342	Evaluation of acute anterior myocardial infarction cases with de-Winter T waves by coronary angiography images
Q55030205	Evaluation of the CRUSADE Risk Score for Predicting Major Bleeding in Patients with Concomitant Kidney Dysfunction and Acute Coronary Syndromes.
Q93161563	Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial
Q45235283	Evidence for a novel racemization process of an asparaginyl residue in mouse lysozyme under physiological conditions
Q41859426	Evolution of Myocardial Infarction and its Biomarkers: A Historical Perspective
Q38392992	Excess mortality and guideline-indicated care following non-ST-elevation myocardial infarction
Q58464204	Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy
Q64064717	Exercise for Prevention and Relief of Cardiovascular Disease: Prognoses, Mechanisms, and Approaches
Q64917002	Exercise-based cardiac rehabilitation for patients following open surgical aortic valve replacement and transcatheter aortic valve implant: a systematic review and meta-analysis.
Q57914770	Exercise-based cardiac rehabilitation for patients with stable angina
Q64093378	Exercise-induced cardiac troponin elevation: An update on the evidence, mechanism and implications
Q50062753	Experiences of a One-hour Algorithm in Chest Pain Patients With a Nonelevated Troponin T at Presentation.
Q88195844	Expert Opinion: Transradial Coronary Artery Procedures: Tips for Success
Q38859458	Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction.
Q92862102	Exploring Current Evidence on the Past, the Present, and the Future of the Heart Team: A Narrative Review
Q92950708	Exploring Patient Experience of Chest Pain Before and After Implementation of an Early Rule-Out Pathway for Myocardial Infarction: A Qualitative Study
Q39154873	Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study
Q38842217	Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events.
Q47676989	External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry
Q53224035	FIT@Home editorial: Supporting a new era of cardiac rehabilitation at home?
Q90597061	Factors Related to Cardiac Troponin T Increase after Participation in a 100 Km Ultra-Marathon
Q39159069	Factors associated with compliance to AHA/ACC performance measures in a myocardial infarction system of care in Brazil.
Q58101150	Factors associated with door-in to door-out delays among ST-segment elevation myocardial infarction (STEMI) patients transferred for primary percutaneous coronary intervention: a population-based cohort study in Ontario, Canada
Q37582557	Factors associated with unattained LDL-cholesterol goals in Chinese patients with acute coronary syndrome one year after percutaneous coronary intervention
Q47161058	Factors related to on-treatment platelet aggregation assessed by multiple electrode aggregometry in percutaneous coronary intervention patients on clopidogrel and aspirin.
Q53577866	Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway (FamouS Triage): ruling out a myocardial infarction at home with the modified HEART score.
Q64997942	Feasibility and implementation of CYP2C19 genotyping in patients using antiplatelet therapy.
Q49720863	Femoral access site closure without prior femoral angiography : A retrospective analysis
Q49489578	Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy
Q54759180	First, do no (irreparable) harm: infarction, bleeding, and subsequent risk of death. The dangers of false equivalency.
Q50085963	Focused update on dual antiplatelet treatment : ESC guidelines 2017
Q31125799	Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data
Q47731200	Frailty and acute coronary syndrome: A structured literature review
Q64277095	Frailty and acute coronary syndrome: does gender matter?
Q90273459	Frailty assessment and risk prediction by GRACE score in older patients with acute myocardial infarction
Q89448035	Frailty syndrome in daily practice of interventional cardiology ward-rationale and design of the FRAPICA trial: A STROBE-compliant prospective observational study
Q57471787	Free triiodothyronine and global registry of acute coronary events risk score on predicting long-term major adverse cardiac events in STEMI patients undergoing primary PCI
Q64996975	Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction.
Q47164229	Gap in gender parity: gender disparities in incidence and clinical impact of chronic total occlusion in non-infarct artery in patients with non-ST-segment elevation myocardial infarction and multivessel coronary artery disease
Q93134803	Gender based differences in clinical and Angiographic characteristics and outcomes of Acute Coronary Syndrome (ACS) in Asian population
Q94570397	Gender disparities in treatment response in octogenarians with acute coronary syndrome
Q99583925	Gender medicine: Lessons from COVID-19 and other medical conditions for designing health policy
Q64117430	Gender-specific associations between atherogenic index of plasma and the presence and severity of acute coronary syndrome in very young adults: a hospital-based observational study
Q38390243	Gender-specific uncertainties in the diagnosis of acute coronary syndrome.
Q58738494	Gene Variant (V34L) and Residual Circulating FXIIIA Levels Predict Short- and Long-Term Mortality in Acute Myocardial Infarction after Coronary Angioplasty
Q39956166	Genetic variants and expression study of FOXP3 gene in acute coronary syndrome in Iranian patients
Q37100870	Geographic variation in the treatment of non-ST-segment myocardial infarction in the English National Health Service: a cohort study.
Q47381059	German cardiac CT registry: indications, procedural data and clinical consequences in 7061 patients undergoing cardiac computed tomography
Q88709430	German contribution to development and innovations in the management of acute myocardial infarction and cardiogenic shock
Q93060480	Global longitudinal strain is a more reproducible measure of left ventricular function than ejection fraction regardless of echocardiographic training
Q57067919	Grade 3 Echocardiographic Diastolic Dysfunction Is Associated With Increased Risk of Major Adverse Cardiovascular Events After Surgery: A Retrospective Cohort Study
Q36347479	Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding
Q58127083	Guideline-Recommended Therapies and Clinical Outcomes According to the Risk for Recurrent Cardiovascular Events After an Acute Coronary Syndrome
Q58697827	Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction
Q47681060	Guidelines in review: Comparison of the 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes and the 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without pe
Q38865373	HEART score performance in Asian and Caucasian patients presenting to the emergency department with suspected acute coronary syndrome
Q57047064	Hand Laser Perfusion Imaging to Assess Radial Artery Patency: A Pilot Study
Q48638914	Health-related quality of life in older patients with acute coronary syndrome randomised to an invasive or conservative strategy. The After Eighty randomised controlled trial
Q50923360	Heart-type fatty acid binding protein is a sensitive biomarker for early AMI detection in troponin negative patients: a pilot study.
Q41106033	Hemostasis pad combined with compression device after transradial coronary procedures: A randomized controlled trial
Q47109397	Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?
Q92744000	High Residual Platelet Reactivity during Aspirin Therapy in Patients with Non-St Segment Elevation Acute Coronary Syndrome: Comparison Between Initial and Late Phases
Q37229316	High Sensitivity Cardiac Troponin Assays - How to Implement them Successfully
Q40230894	High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study
Q48183837	High risk of stent thrombosis in the first 6 months after coronary stenting: Do not discontinue clopidogrel early after ACS.
Q53838655	High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: results from the TRAPID-AMI study.
Q42117264	High sensitivity troponin T and I reflect mitral annular plane systolic excursion being assessed by cardiac magnetic resonance imaging
Q47772072	High sensitivity troponins in contemporary cardiology practice: are we turning a corner?
Q57814170	High-Sensitivity Cardiac Troponin I and Clinical Risk Scores in Patients With Suspected Acute Coronary Syndrome
Q47782446	High-Sensitivity Cardiac Troponin I as a Gatekeeper for Coronary Computed Tomography Angiography and Stress Testing in Patients with Acute Chest Pain
Q97646623	High-Sensitivity Cardiac Troponin I vs a Clinical Chemistry Score for Predicting All-Cause Mortality in an Emergency Department Population
Q49600199	High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome
Q38608703	High-Sensitivity Cardiac Troponin for the Diagnosis of Patients with Acute Coronary Syndromes
Q90363040	High-Sensitivity Troponin T Testing: Consequences on Daily Clinical Practice and Effects on Diagnosis of Myocardial Infarction
Q93053477	High-Sensitivity Troponin and the Application of Risk Stratification Thresholds in Patients With Suspected Acute Coronary Syndrome
Q36948782	High-density lipoprotein cholesterol values independently and inversely predict cardiac troponin T and I concentration
Q48244270	High-sensitive troponin T assay can predict anthracycline- and trastuzumab-induced cardiotoxicity in breast cancer patients.
Q64883945	High-sensitivity Troponins after a Standardized 2-hour Treadmill Run.
Q39223912	High-sensitivity assays for troponin in patients with cardiac disease
Q42364013	High-sensitivity cardiac troponin I assays in the diagnosis of acute myocardial infarction
Q50059910	High-sensitivity cardiac troponin T in young, healthy adults undergoing non-cardiac surgery.
Q38889348	High-sensitivity cardiac troponin assays and unstable angina
Q39272975	High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification
Q26738522	High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages
Q91657682	High-sensitivity troponin T and long-term adverse cardiac events among patients presenting with suspected acute coronary syndrome in Singapore
Q58737942	High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial
Q38722294	Highly sensitive troponin and coronary computed tomography angiography in the evaluation of suspected acute coronary syndrome in the emergency department
Q94502856	History of major bleeding predicts risk of clinical outcome of patients with atrial fibrillation: results from the COOL-AF registry
Q34558365	Home-based versus centre-based cardiac rehabilitation.
Q93026920	How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study
Q90718204	How to choose a point-of-care testing for troponin
Q44528139	How to keep on going: Editorial comment on The long-term effects of a randomized trial comparing aerobic interval versus continuous training in coronary artery disease patients: one-year data from the SAINTEX-CAD study
Q37472878	III SBC Guidelines on the Analysis and Issuance of Electrocardiographic Reports - Executive Summary
Q52768604	IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult.
Q58746571	IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
Q39751079	Identification of High-Risk Patients with Non-ST Segment Elevation Myocardial Infarction using Strain Doppler Echocardiography: Correlation with Cardiac Magnetic Resonance Imaging
Q47584608	Identification of coronary artery calcification can optimize risk stratification in patients with acute chest pain
Q47679862	Identifying patients with acute total coronary occlusion in NSTEACS: finding the high-risk needle in the haystack
Q89964322	Imbalance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in Epicardial Adipose Tissue Is Associated With Non ST-Segment Elevation Acute Coronary Syndrome
Q90395069	Impact of Morphine Treatment on Infarct Size and Reperfusion Injury in Acute Reperfused ST-Elevation Myocardial Infarction
Q58129990	Impact of Obstructive Sleep Apnea on Platelet Function Profiles in Patients With Acute Coronary Syndrome Taking Dual Antiplatelet Therapy
Q91687307	Impact of One-Catheter Strategy with TIG I Catheter on Coronary Catheterization Performance and Economic Costs
Q92662541	Impact of Right Atrial Physiology on Heart Failure and Adverse Events after Myocardial Infarction
Q50073758	Impact of Test Conditions on ADP-Induced Platelet Function Results With the Multiplate Assay: Is Further Standardization Required?
Q47609523	Impact of anemia on long-term outcomes after percutaneous coronary intervention for chronic total occlusion
Q36362768	Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
Q38984352	Impact of betablockers on general and local outcome in patients hospitalized for lower extremity peripheral artery disease: The COPART Registry
Q54428168	Impact of computed tomography myocardial perfusion following computed tomography coronary angiography on downstream referral for invasive coronary angiography, revascularization and, outcome at 12 months.
Q36784692	Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndrome
Q47153010	Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions
Q99578852	Impact of coronary angioplasty in elderly patients with non-ST-segment elevation myocardial infarction
Q37525860	Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction.
Q48360041	Impact of in-hospital blood pressure variability on cardiovascular outcomes in patients with acute coronary syndrome.
Q99417036	Impact of infection in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: insight from a multicentre observational cohort from China
Q37424006	Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus.
Q26748904	Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors
Q33792006	Impact of serum erythropoietin level on collateral vessel development in patients with coronary artery disease.
Q50094093	Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.
Q40890811	Impact of transradial coronary intervention on bleeding complications in octogenarians
Q47555409	Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice
Q97527663	Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China
Q55083407	Impaired aspirin-mediated platelet function inhibition in resuscitated patients with acute myocardial infarction treated with therapeutic hypothermia: a prospective, observational, non-randomized single-centre study.
Q64898665	Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock.
Q93001069	Implementation of High-Sensitivity Cardiac Troponin: Challenges From the International Experience
Q47705387	Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience
Q50094174	Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
Q91757445	Improved quality of samples and laboratory turnaround time using 3.5 mL low vacuum BD Vacutainer® Barricor tubes in the emergency department
Q57146961	Improving Arterial Wall Characteristics in Patients After Myocardial Infarction with a Very Low Dose of Fluvastatin and Valsartan: A Proof-of-Concept Study
Q64063495	Improving the Diagnosis of Culprit Left Circumflex Occlusion With Acute Myocardial Infarction in Patients With a Nondiagnostic 12-Lead ECG at Presentation: A Retrospective Cohort Study
Q94062482	Improving the prescription of secondary prevention medications in patients with acute coronary syndrome in acute assessment unit: a quality improvement project
Q94415068	In Reply
Q89294390	In dubious battle: bleeding versus ischemic events
Q37733638	In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvascu
Q88228778	In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute
Q48252169	In-hospital outcomes in invasively managed acute myocardial infarction patients who receive morphine.
Q38683937	Incidence and Causes for Early Ticagrelor Discontinuation: A "Real-World" Dutch Registry Experience.
Q38858932	Incidence of intracranial bleeds in new users of low-dose aspirin: a cohort study using The Health Improvement Network.
Q92502611	Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study
Q47820170	Incidence, treatment strategies and outcomes of acute coronary syndrome with and without ongoing myocardial ischaemia: results from the CZECH-3 registry
Q52752388	Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor.
Q64066315	Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction
Q61453689	Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
Q91878368	Increased renal cortical stiffness is associated with coronary artery disease severity in patients with acute coronary syndrome
Q37481596	Indications, algorithms, and outcomes for coronary artery bypass surgery in patients with acute coronary syndromes
Q47565505	Inequalities in access to cardiac rehabilitation after an acute coronary syndrome: the EPiHeart cohort
Q64254694	Influence of age on the effect of reduced renal function on outcomes in patients with coronary artery disease
Q38668536	Influence of minor deterioration of renal function after PCI on outcome in patients with ST-elevation myocardial infarction.
Q88194461	Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction
Q55279914	Initial Phase NT-proBNP, but Not Copeptin and High-Sensitivity Cardiac Troponin-T Yielded Diagnostic and Prognostic Information in Addition to Clinical Assessment of Out-of-Hospital Cardiac Arrest Patients With Documented Ventricular Fibrillation.
Q91992612	Integrated diagnostics: the future of laboratory medicine?
Q90608639	Interleukin-18 in patients with acute coronary syndromes
Q55404181	International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management.
Q57211271	International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Commi
Q37617057	International patterns of dual antiplatelet therapy duration after acute coronary syndromes
Q38886151	Interventional cardiology, where real life and science do not necessarily meet
Q53964836	Interventional cardiology: Polymer-free drug-eluting stents - a safe and effective option for ACS.
Q39026592	Interventional therapies in acute myocardial infarction complicated by cardiogenic shock
Q91862547	Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use
Q91979710	Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox
Q41158533	Invasive coronary angiography in patients with acute exacerbated COPD and elevated plasma troponin
Q42224856	Invasive management of acute coronary syndromes
Q64277042	Invasive strategy in elderly patients with acute coronary syndrome in 2018: close to the truth?
Q99622841	Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data
Q92922224	Investigating the Manifestation of Coronary Artery Disease and Determining the Role of Effective Factors in the Need for Pacemaker Insertion in These Patients
Q88207292	Is Complete Revascularisation Mandated for all Patients with Multivessel Coronary Artery Disease?
Q45052601	Is Telemetry Monitoring Useful in Patients Admitted With Suspected Acute Coronary Syndrome?
Q92824446	Is high-sensitivity troponin, alone or in combination with copeptin, sensitive enough for ruling out NSTEMI in very early presenters at admission? A post hoc analysis performed in emergency departments
Q38860495	Is it time to take bare metal stents off the catheter laboratory shelf?
Q36709178	Is there a role for a local inpatient CT coronary angiography service in selected patients with acute coronary syndrome? A cohort analysis of inpatient tertiary centre referrals for invasive coronary angiography
Q92954739	Is there a role for ischemia detection after an acute myocardial infarction?
Q90720028	Ischemia Reperfusion Injury: Mechanisms of Damage/Protection and Novel Strategies for Cardiac Recovery/Regeneration
Q36591086	Ischemic Left Ventricular Perforation Covered by a Thrombus in a Patient Presenting with Cerebral Ischemia: Importance of Time-Sensitive Performance and Adequate Interpretation of Bedside Transthoracic Echography
Q50126198	Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y12 receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgery
Q90724407	Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19
Q60931790	KSHF Guidelines for the Management of Acute Heart Failure: Part I. Definition, Epidemiology and Diagnosis of Acute Heart Failure
Q58037992	Kurzdarstellung
Q90107579	LDL-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction - nationwide cohort study, 2013-2017
Q89563788	LMU Munich: platelet inhibition novel aspects on platelet inhibition and function
Q63247371	Laboratory Medicine is Faced with the Evolution of Medical Practice
Q39254915	Late thrombotic events after bioresorbable scaffold implantation: a systematic review and meta-analysis of randomized clinical trials
Q92059065	Left ventricular ejection fraction adds value over the GRACE score in prediction of 6-month mortality after ACS: the MADDEC study
Q59336127	Letter on "Pre-hospital transthoracic echocardiography for early identification of non-ST-elevation myocardial infarction in patients with acute coronary syndrome"
Q92385038	Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018
Q89252127	Lights and shadows of long-term dual antiplatelet therapy in "real life" clinical scenarios
Q52376003	Linking hospital patient records for suspected or established acute coronary syndrome in a complex secondary care system: a proof-of-concept e-registry in NHS Scotland.
Q92862084	Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries
Q90319529	Lipid management for coronary heart disease patients: an appraisal of updated international guidelines applying Appraisal of Guidelines for Research and Evaluation II-clinical practice guideline appraisal for lipid management in coronary heart disea
Q92028509	Long-Term Survival after Acute Myocardial Infarction in Lithuania during Transitional Period (1996-2015): Data from Population-Based Kaunas Ischemic Heart Disease Register
Q39093174	Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.
Q38726573	Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
Q58598431	Long-term benefits of high-intensity atorvastatin therapy in Chinese acute coronary syndrome patients undergoing percutaneous coronary intervention: A retrospective study
Q64080249	Long-term clinical outcome between beta-blocker with ACEI or ARB in patients with NSTEMI who underwent PCI with drug-eluting stents
Q37692145	Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease
Q92100398	Long-term effect of clopidogrel in patients with and without diabetes: A systematic review and meta-analysis of randomized controlled trials
Q38407290	Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study
Q50899648	Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination (BASKET-PROVE) sub-study.
Q90303159	Loss of CXCR4 on non-classical monocytes in participants of the Women's Interagency HIV Study (WIHS) with subclinical atherosclerosis
Q90224973	Low High-Sensitivity Troponin Thresholds Identify Low-Risk Patients With Chest Pain Unlikely to Benefit From Further Risk Stratification
Q89880934	Low Systolic Blood Pressure and Mortality in Elderly Patients After Acute Myocardial Infarction
Q47213003	Low body weight and clinical outcomes in acute coronary syndrome patients: results of the ACHILLES Registry.
Q53401039	Low rate fluoroscopy in cardiac catheterization: Toward a new standard?
Q52342075	Low-Dose Unfractionated Heparin with Sequential Enoxaparin in Patients with Diabetes Mellitus and Complex Coronary Artery Disease during Elective Percutaneous Coronary Intervention.
Q42281565	Machine Learning Improves Risk Stratification After Acute Coronary Syndrome
Q92643141	Machine Learning to Predict the Likelihood of Acute Myocardial Infarction
Q99617593	Machine learning-based CT fractional flow reserve assessment in acute chest pain: first experience
Q59795756	Machine-learned models using hematological inflammation markers in the prediction of short-term acute coronary syndrome outcomes
Q64238174	Management of ST-elevation myocardial infarction in the setting of anterior epistaxis: focused on antiplatelet and antithrombotic therapies
Q92423897	Management of a decompensated acute-on-chronic intracranial venous sinus thrombosis
Q40478828	Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis.
Q91994233	Management of cardiogenic shock complicating acute myocardial infarction: A review
Q88690653	Management of cardiogenic shock complicating myocardial infarction
Q39457838	Management of dental patients receiving antiplatelet therapy or chronic oral anticoagulation: A review of the latest evidence
Q39314230	Management of elderly patients with a non-ST-segment-elevation acute coronary syndrome
Q55284946	Management of hyperglycemia during and in the immediate follow-up of acute coronary syndrome.
Q41982381	Management of patients with chest pain presenting to the emergency department: in need for the implementation of the 1 h rapid rule-out algorithm using high-sensitivity troponin I assays in clinical practice
Q38880890	Management of refractory cardiogenic shock.
Q53745697	Managing acute coronary syndromes: troponin and DAPT in the real world.
Q55317013	Managing chest pain patients in general practice: an interview-based study.
Q38724843	Medical Therapy and Recurrent Ischemic Events in High Risk Patients Surviving their Myocardial Infarction for at Least 12 Months: Comparison of Patients with ST Elevation Versus Non-ST Elevation Myocardial Infarction
Q91996661	Medical care of acute myocardial infarction patients in a resource limiting country, Trinidad: a cross-sectional retrospective study
Q50217749	Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting
Q42336179	Merits of Invasive Strategy in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome
Q49360165	Meta-Analysis of the Safety and Efficacy of the Oral Anticoagulant Agents (Apixaban, Rivaroxaban, Dabigatran) in Patients With Acute Coronary Syndrome.
Q38734885	Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease
Q58799733	Metabolism of ticagrelor in patients with acute coronary syndromes
Q91797819	Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study
Q28076541	MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?
Q48351308	Mild troponin elevation in patients admitted to the emergency department with atrial fibrillation: 30-day post-discharge prognostic significance.
Q64111597	Missed Acute Myocardial Infarction (MAMI) in a rural and regional setting
Q47570107	Missed Opportunities in Symptomatic Patients before a First Acute Coronary Syndrome: The EPIHeart Cohort Study.
Q58554416	Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from the First Euro Heart Failure Survey
Q94476711	Modern diagnostics in emergency medicine
Q47709533	More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions
Q36273176	Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review
Q90026889	Mortality reduction with physical activity in patients with and without cardiovascular disease
Q55715476	Multi-centre evaluation of recent troponin assays for the diagnosis of NSTEMI.
Q92152497	Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry
Q98949642	Multimodality imaging in takotsubo syndrome: a joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE)
Q52803111	Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort.
Q39432248	Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis
Q50899936	Murine Left Anterior Descending (LAD) Coronary Artery Ligation: An Improved and Simplified Model for Myocardial Infarction.
Q90053907	Myocardial infarction patients' learning needs: Perceptions of patients, family members and nurses
Q92462680	Myocardial infarction with non-obstructive coronary arteries: A comprehensive review and future research directions
Q60918724	NMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort
Q64094571	NSTEMI treatment: should we always follow the guidelines?
Q47627874	Nationwide claims data validated for quality assessments in acute myocardial infarction in the Netherlands.
Q37556419	Neurohormonal Activation After Atrial Fibrillation Initiation in Patients Eligible for Catheter Ablation: A Randomized Controlled Study.
Q26765488	New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?
Q38817144	New directions for pharmacotherapy in the treatment of acute coronary syndrome.
Q59329014	Nocturnal respiratory rate as a predictor of mortality in patients with acute coronary syndrome
Q92619493	Non-HDL-c/TC: A Novel Lipid-Related Marker in the Assessment of Severity of Coronary Artery Lesions and Cardiovascular Outcomes
Q90055260	Non-ST elevation acute coronary syndrome in the elderly
Q49968211	Non-ST elevation acute coronary syndromes: timing and selection of early invasive management, ECG monitoring need, DAPT duration, pathogenesis of recurrence and beware of delirium in the intensive/acute cardiac care unit!
Q52662455	Non-ST-Segment-Elevation Myocardial Infarction Among Patients With Chronic Kidney Disease: A Propensity Score-Matched Comparison of Percutaneous Coronary Intervention Versus Conservative Management.
Q90468299	Non-atherosclerotic causes of acute coronary syndromes
Q58565459	Non-cardiac chest pain: prognosis and secondary healthcare utilisation
Q88482868	Non-coding RNAs as biomarkers for acute myocardial infarction
Q89177871	Non-vitamin K Antagonist Oral Anticoagulant After Acute Coronary Syndrome: Is There a Role?
Q47579592	Noninvasive Cardiac Testing vs Clinical Evaluation Alone in Acute Chest Pain: A Secondary Analysis of the ROMICAT-II Randomized Clinical Trial.
Q94230261	Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis
Q58739842	Novel biochemical predictors of unfavorable prognosis for stable coronary disease
Q33615459	Novel biomarkers for cardiovascular risk prediction
Q93159889	Novel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndrome
Q38986700	Novel oral anticoagulants for acute coronary syndrome
Q64389509	Nuclear factor kappa B in patients with a history of unstable angina: case re-opened
Q64115668	Observation of early strut coverage after polymer-free biolimus-A9 coated stent by optical frequency domain imaging
Q39755324	On- versus off-hour care for patients with non-ST-segment elevation myocardial infarction in Germany : Exemplary results within the chest pain unit concept
Q49088428	One-year and longer dual antiplatelet therapy after an acute coronary syndrome: a Belgian position paper
Q90608191	Optimal Timing of Invasive Coronary Angiography following NSTEMI
Q49114283	Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues….
Q55260829	Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
Q38706266	Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence
Q44588219	Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome : Practical lessons from a review
Q55204798	Optimal treatment of patients with NSTE-ACS in the Dutch health care system.
Q38817125	Optimizing the Use of Cangrelor in the Real World
Q64939825	Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome.
Q38754884	Oral antiplatelet therapy: impact for transfusion medicine.
Q89395845	Out-of-Hospital Cardiac Arrest in Acute Myocardial Infarction and STEMI Networks
Q38901631	Out-of-hospital cardiac arrest survivors sent for emergency angiography: a clinical score for predicting acute myocardial infarction
Q97093983	Outcome in Patients Resuscitated following Myocardial Infarction with Acute Kidney Injury
Q47147553	Outcome of Stable Patients With Acute Myocardial Infarction and Coronary Artery Bypass Surgery Within 48 Hours: A Single-Center, Retrospective Experience
Q50864248	Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial b
Q40642186	Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry
Q38661576	Outcomes of Patients Presenting With Clinical Indices of Spontaneous Reperfusion in ST-Elevation Acute Coronary Syndrome Undergoing Deferred Angiography.
Q41101718	Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization
Q89157453	Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis
Q46283292	Oxidative stress in ischemia and reperfusion: current concepts, novel ideas and future perspectives
Q90668835	Oxygen Treatment in Intensive Care and Emergency Medicine
Q39466995	P2Y12 Inhibitor Pre-Treatment in Non-ST-Elevation Acute Coronary Syndrome: A Decision-Analytic Model
Q38830465	P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries
Q48560473	PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation
Q91643614	PURL: Should you switch the DAPT agent one month after ACS?
Q38626782	Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.
Q38704291	Patient education in the management of coronary heart disease.
Q49938128	Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests
Q90018054	Percutaneous closure of an iatrogenic aorto-right atrial fistula of the sinus of Valsalva through total arm approach: a case report
Q64114421	Percutaneous coronary intervention in patients hospitalized for non-ST-elevation myocardial infarction and the risk of postdischarge ischemic stroke at 6-month, 1-year, and 3-year follow-ups
Q47763813	Percutaneous coronary intervention in the elderly: are drug coated balloons the future?
Q47579858	Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials
Q92741233	Performance of Copeptin for Early Diagnosis of Acute Myocardial Infarction in an Emergency Department Setting
Q38374170	Performance of highly sensitive cardiac troponin T assay to detect ischaemia at PET-CT in low-risk patients with acute coronary syndrome: a prospective observational study
Q47095585	Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register
Q41520780	Perioperative management of antiplatelet treatment in patients undergoing isolated coronary artery bypass grafting in Dutch cardiothoracic centres
Q53155923	Persistent Renal Dysfunction After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
Q33589630	Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors
Q58696101	Personalization of injection protocols to the individual patient's blood volume and automated tube voltage selection (ATVS) in coronary CTA
Q36133181	Phagocytosis of apoptotic cells: a matter of balance
Q42694846	Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects
Q88930479	Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function
Q88636297	Pharmacotherapy: Current role of β-blockers after MI in patients without HF
Q98614882	Physiology-guided revascularization versus optimal medical therapy of non-culprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial
Q88955111	Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients
Q61809495	Platelet Reactivity And Circulating Platelet-Derived Microvesicles Are Differently Affected By P2Y Receptor Antagonists
Q36216424	Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome.
Q40564706	Platelet aggregation inhibitors and anticoagulants during ophthalmic interventions
Q49613379	Platelet-to-lymphocyte ratio predicts contrast-induced acute kidney injury in diabetic patients with ST-elevation myocardial infarction
Q90403621	Platelets Are at the Nexus of Vascular Diseases
Q49711932	Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making?
Q87642215	Point-of-care testing of cardiac autonomic function for risk assessment in patients with suspected acute coronary syndromes
Q67429078	Polyhedral erythrocytes in intracoronary thrombus and their association with reperfusion in myocardial infarction.
Q38954355	Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients
Q92612178	Position Statement on Indications of Echocardiography in Adults - 2019
Q47237796	Positive predictive values of peripheral arterial and venous thrombosis codes in French hospital database
Q36246538	Post resuscitation care--some words of caution and a call for action
Q93196470	Post-exercise high-sensitivity troponin T levels in patients with suspected unstable angina
Q90346253	Post-systolic shortening predicts heart failure following acute coronary syndrome
Q36216440	Postprocedural radial artery occlusion rate using a sheathless guiding catheter for left ventricular endomyocardial biopsy performed by transradial approach
Q50194869	Practical challenges regarding in-hospital telemetry monitoring require the development of European practice standards
Q53250732	Practical considerations for cangrelor use in patients with acute coronary syndromes.
Q60189656	Prasugrel in critically ill patients
Q31116489	Pre- and in-hospital antithrombotic management patterns and in-hospital outcomes in patients with acute coronary syndrome: data from the Turkish arm of the EPICOR study
Q47302039	Pre-Clinical Tests of an Integrated CMOS Biomolecular Sensor for Cardiac Diseases Diagnosis.
Q88287398	Pre-hospital and hospital delay in patients with non-ST elevation acute coronary syndromes in tertiary care
Q48096262	Pre-hospital transthoracic echocardiography for early identification of non-ST-elevation myocardial infarction in patients with acute coronary syndrome.
Q59329017	Pre-test characteristics of unstable angina patients with obstructive coronary artery disease confirmed by coronary angiography
Q38682012	Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent?
Q40478267	Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry.
Q64242233	Predicting Long-Term Mortality after Acute Coronary Syndrome Using Machine Learning Techniques and Hematological Markers
Q92658704	Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest - A propensity score-matched analysis
Q37441199	Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores
Q93117519	Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction
Q38837498	Predictive values of D-dimer assay, GRACE scores and TIMI scores for adverse outcome in patients with non-ST-segment elevation myocardial infarction
Q38648931	Predictors and clinical implication of high-sensitivity cardiac troponin-I elevation following diagnostic cardiac catheterisations.
Q47309703	Predictors of adherence to treatment by patients with coronary heart disease after percutaneous coronary intervention.
Q99628214	Pregnancy-Associated Myocardial Infarction: Prevalence, Causes, and Interventional Management
Q47150007	Pregnancy-related conditions and premature coronary heart disease in adult offspring.
Q37609683	Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis.
Q64119668	Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study
Q92732014	Presenting Symptoms in Men and Women Diagnosed With Myocardial Infarction Using Sex-Specific Criteria
Q89974218	Prevalence and clinical profile of patients with myocardial infarction with non-obstructive coronary arteries in Turkey (MINOCA-TR): A national multi-center, observational study
Q91643864	Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndrome
Q59332957	Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project
Q88869138	Prevalence and outcome of patients referred for chest pain with high-sensitivity troponin elevation and no diagnosis at discharge
Q46327219	Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome
Q90071333	Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Q96304398	Preventing myocardial infarction: use and limitation of non-invasive imaging modalities
Q47780284	Preventing recurrent events in survivors of acute coronary syndromes in Australia: consensus recommendations using the Delphi process
Q55098398	Prime time for the sweet spot in timing of coronary invasive approach in patients with non-ST elevation myocardial infarction.
Q47261452	Prior exposure to aspirin in acute coronary syndrome patients: a cardiovascular risk marker or a predictor of adverse outcome? A contemporary data of a national registry
Q58123848	Prognostic Impact of Acute Myocardial Infarction in Patients Presenting With Ventricular Tachyarrhythmias and Aborted Cardiac Arrest
Q60922951	Prognostic Utility of Indoxyl Sulfate for Patients with Acute Coronary Syndrome
Q37556404	Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention
Q90041460	Prognostic Value of a Novel and Established High-Sensitivity Troponin I Assay in Patients Presenting with Suspected Myocardial Infarction
Q92869596	Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention
Q47238861	Prognostic comparison between creatinine-based glomerular filtration rate formulas for the prediction of 10-year outcome in patients with non-ST elevation acute coronary syndrome treated by percutaneous coronary intervention
Q92533408	Prognostic impact of alkaline phosphatase for in-hospital mortality in patients with acute coronary syndrome: a prospective cohort study in China
Q59795641	Prognostic impact of bundle branch block after acute coronary syndrome. Does it matter if it is left of right?
Q49813626	Prognostic impacts of Rho-kinase activity in circulating leucocytes in patients with vasospastic angina
Q91622756	Prognostic implications of post-percutaneous coronary intervention neutrophil-to-lymphocyte ratio on infarct size and clinical outcomes in patients with acute myocardial infarction
Q47368235	Prognostic significance of non-chest pain symptoms in patients with non-ST-segment elevation myocardial infarction.
Q89994586	Prognostic value of admission electrocardiographic findings in non-ST-segment elevation myocardial infarction
Q36235438	Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population: A meta-analysis
Q33168331	Prognostic value of ejection fraction in patients admitted with acute coronary syndrome: A real world study
Q92643795	Prognostic value of frailty in elderly patients with acute coronary syndrome: a systematic review and meta-analysis
Q92846891	Prolonged dual antiplatelet therapy in patients with non-ST-segment elevation myocardial infarction: 2-year findings from EPICOR Asia
Q38791916	Prooxidant-antioxidant balance, hsTnI and hsCRP: mortality prediction in haemodialysis patients, two-year follow-up
Q91788809	Protease-activated receptor-mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors
Q36836327	Providing Rapid Out of Hospital Acute Cardiovascular Treatment 4 (PROACT-4).
Q47690968	Pulse pressure in acute coronary syndromes: Comparative prognostic significance with systolic blood pressure
Q52814619	Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association.
Q92148236	Quality of Intra-Hospital Nutritional Counseling in Patients with STEMI in the Public and Private Health Networks of Sergipe: The VICTIM Register
Q33685850	Quality of analgesia in physician-operated telemedical prehospital emergency care is comparable to physician-based prehospital care - a retrospective longitudinal study
Q46390050	Quantifying the Release of Biomarkers of Myocardial Necrosis from Cardiac Myocytes and Intact Myocardium.
Q91823060	RAPID-CPU: a prospective study on implementation of the ESC 0/1-hour algorithm and safety of discharge after rule-out of myocardial infarction
Q57044275	Randomised controlled trial of the Limit of Detection of Troponin and ECG Discharge (LoDED) strategy versus usual care in adult patients with chest pain attending the emergency department: study protocol
Q55080711	Ranolazine: A true pluripotent cardiovascular drug or jack of all trades, master of none?
Q92550774	Rapid use of high-sensitive cardiac troponin I for ruling-in and ruling-out of acute myocardial infarction (RACING-MI): study protocol
Q64080262	Rate of anticoagulant use, and factors associated with not prescribing anticoagulant in older Thai adults with non-valvular atrial fibrillation: A multicenter registry
Q48628910	Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study
Q92224849	Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with
Q38754352	Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease
Q92830991	Readmission and processes of care across weekend and weekday hospitalisation for acute myocardial infarction, heart failure or stroke: an observational study of the National Readmission Database
Q38999087	Real world insights on the initiation and treatment duration of oral antiplatelets in acute coronary syndromes: a retrospective cohort study.
Q47580533	Real-world clopidogrel utilization in acute coronary syndromes: patients selection and outcomes in a single-center experience
Q91810438	Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study
Q58767646	Received care compared to ADP-guided care of patients admitted to hospital with chest pain of possible cardiac origin
Q41841561	Recording a diagnosis of stroke, transient ischaemic attack or myocardial infarction in primary healthcare and the association with dispensation of secondary preventive medication: a registry-based prospective cohort study
Q64058326	Recurrent chest pain: 'what is essential is invisible to the eye?'
Q64988378	Red blood cell transfusion in patients with ST-elevation myocardial infarction-a meta-analysis of more than 21,000 patients.
Q64097019	Reducing delay in patients with acute coronary syndrome and other time-critical conditions: a systematic review to identify the behaviour change techniques associated with effective interventions
Q92562261	Reinforcement of patient education improved physicians' adherence to guideline-recommended medical therapy after acute coronary syndrome
Q48513943	Relation of Age and Health-Related Quality of Life to Invasive Versus Ischemia-Guided Management of Patients with Non-ST Elevation Myocardial Infarction
Q48328549	Relation of presystolic wave on doppler examination to syntax score in patients with acute myocardial infarction.
Q52662453	Relations of Sex to Diagnosis and Outcomes in Acute Coronary Syndrome.
Q37039218	Relationship between ADP-induced platelet-fibrin clot strength and anti-platelet responsiveness in ticagrelor treated ACS patients
Q37556037	Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes
Q51366879	Release kinetics of high-sensitivity cardiac troponins I and T and troponin T upstream open reading frame peptide (TnTuORF) in clinically induced acute myocardial infarction
Q47149127	Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D).
Q87944631	Reliability of the CARE rule and the HEART score to rule out an acute coronary syndrome in non-traumatic chest pain patients
Q50100389	Renal Dysfunction Influences the Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin I.
Q51822693	Renal Dysfunction: How to Think About That in Acute Coronary Syndromes.
Q97418239	Renal resistive index and long-term outcome in patients with coronary artery disease
Q40667408	Reproducibility of coronary atherosclerotic plaque characteristics in populations with low, intermediate, and high prevalence of coronary artery disease by multidetector computer tomography: a guide to reliable visual coronary plaque assessments
Q97646618	Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary Syndrome
Q92419589	Retinal Vascular Density as A Novel Biomarker of Acute Renal Injury after Acute Coronary Syndrome
Q38799167	Revascularization in complex multivessel coronary artery disease after FREEDOM. Is there an indication for PCI and drug-eluting stents?
Q48219571	Reversal of the platelet inhibitory effect of the P2Y12 inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issue.
Q38765117	Reviewing the controversy surrounding pre-treatment with P2Y12 inhibitors in acute coronary syndrome patients
Q92133268	Revisiting the Biological Variability of Cardiac Troponin: Implications for Clinical Practice
Q55438710	Rheolytic effects of left main mid-shaft/distal stenting: a computational flow dynamic analysis.
Q64912028	Right ventricular function in patients presenting with non-ST-segment elevation myocardial infarction undergoing an invasive approach.
Q99615004	Risk Assessment Using Risk Scores in Patients with Acute Coronary Syndrome
Q47617519	Risk Scoring to guide anti-platelet therapy post percutaneous coronary intervention (PCI) for acute-coronary syndrome (ACS) results in improved clinical outcomes.
Q90044804	Risk Stratification Using High-Sensitivity Cardiac Troponin T in Patients With Suspected Acute Coronary Syndrome
Q52355127	Risk Stratification and in Hospital Morality in Patients Presenting with Acute Coronary Syndrome (ACS) in Bahrain.
Q93163340	Risk Stratification in Patients with Coronary Artery Disease: A Practical Walkthrough in the Landscape of Prognostic Risk Models
Q55263088	Risk evaluation of new-onset atrial fibrillation complicating ST-segment elevation myocardial infarction: a comparison between GRACE and CHA2DS2-VASc scores.
Q47549098	Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation
Q55397215	Risk prediction in stable cardiovascular disease using a high-sensitivity cardiac troponin T single biomarker strategy compared to the ESC-SCORE.
Q39000195	Risk stratification after ST-segment elevation myocardial infarction.
Q58760095	Risk stratification and role for additional diagnostic testing in patients with acute chest pain and normal high-sensitivity cardiac troponin levels
Q49238714	Risk stratification based on components of the complete blood count in patients with acute coronary syndrome: A classification and regression tree analysis
Q57482608	Risk stratification in non-ST elevation acute coronary syndromes: searching for the right formula
Q93227769	Risk stratification vs routine intensive care stay in non ST segment elevation myocardial infarction (NSTEMI)
Q55429574	Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment.
Q38635266	Role of Cardiac Magnetic Resonance Imaging in Myocardial Infarction.
Q38401281	Role of Genetic Testing in Patients undergoing Percutaneous Coronary Intervention
Q38974706	Role of New Antiplatelet Drugs on Cardiovascular Disease: Update on Cangrelor.
Q28069234	Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology
Q90176091	Roles and Mechanisms of Hawthorn and Its Extracts on Atherosclerosis: A Review
Q36891753	Roles of High-Density Lipoprotein Cholesterol in Patients With Acute Myocardial Infarction
Q47138444	Routine beta-blocker administration following acute myocardial infarction: why still an unsolved issue?
Q40723901	ST elevation myocardial infarction.
Q57128257	ST segment elevation myocardial infarction (STEMI) patients are more likely to achieve lipid-lowering treatment goals: A retrospective analysis of patients presenting with first acute coronary syndromes
Q92616623	ST-segment re-elevation following primary angioplasty in acute myocardial infarction with patent infarct-related artery: impact on left ventricular function recovery and remodeling
Q52310273	Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation.
Q52682104	Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study.
Q49716827	Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial
Q38760067	Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes
Q64237046	Safety of bivalirudin versus unfractionated heparin in endovascular revascularization of peripheral arteries in short- and long-term follow-up
Q37666397	Screening Characteristics of TIMI Score in Predicting Acute Coronary Syndrome Outcome; a Diagnostic Accuracy Study
Q89819882	Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease
Q43559706	Secondary analysis of frequency, circumstances and consequences of calculation errors of the HEART (history, ECG, age, risk factors and troponin) score at the emergency departments of nine hospitals in the Netherlands
Q38768288	Selecting patients with non-ST-elevation acute coronary syndrome for coronary angiography: a nationwide clinical vignette study in the Netherlands
Q55484350	Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries.
Q64078326	Serum of patients with acute myocardial infarction prevents inflammation in iPSC-cardiomyocytes
Q33775454	Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor.
Q64890612	Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention.
Q53841520	Sex differences in presenting symptoms of acute coronary syndrome: the EPIHeart cohort study.
Q61842044	Sex differences in quality indicator attainment for myocardial infarction: a nationwide cohort study
Q47105774	Sex-Based Differences in the Performance of the HEART Score in Patients Presenting to the Emergency Department With Acute Chest Pain
Q47260286	Sex-related inequalities in management of patients with acute coronary syndrome-results from the EURHOBOP study
Q99564847	Sex-specific effects of implementing a high-sensitivity troponin I assay in patients with suspected acute coronary syndrome: results from SWEDEHEART registry
Q88711560	Shock Management for Cardio-surgical ICU Patients - The Golden Hours
Q89992919	Short- and long-term follow-up of antithrombotic management patterns in patients hospitalized with acute coronary syndrome: Indian subgroup of EPICOR Asia study
Q89848891	Short-Term Prognosis Value of sST2 for an Unfavorable Outcome in Hypertensive Patients
Q64917653	Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: a meta-analysis.
Q48033043	Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally?
Q90083826	Simple risk score based on the China Acute Myocardial Infarction registry for predicting in-hospital mortality among patients with non-ST-segment elevation myocardial infarction: results of a prospective observational cohort study
Q52604162	Single and dual antiplatelet therapy in elderly patients of medically managed myocardial infarction.
Q38970275	Single or dual antiplatelet therapy after PCI.
Q48639647	Some highlights of a 47 year career in research
Q52719501	Specific Pharmacological Profile of A2A Adenosine Receptor Predicts Reduced Fractional Flow Reserve in Patients With Suspected Coronary Artery Disease.
Q55312806	Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association.
Q90092645	Spontaneous Epidural Hematoma of the Cervical Spine Following Thrombolysis in a Patient with STEMI-Two Medical Specialties Facing a Rare Dilemma
Q59335178	Spontaneous coronary artery dissection: contemporary aspects of diagnosis and patient management
Q52589127	Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.
Q37437857	Staged versus "one-time" multivessel intervention in elderly patients with non-ST-elevation acute coronary syndrome
Q37121221	Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspective
Q52330465	Stenting in Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.
Q48774020	Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome.
Q92075011	Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing
Q36874702	Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants
Q90182016	Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
Q58700176	Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI)
Q37236462	Study to Improve Cardiovascular Outcomes in high-risk older patieNts (ICON1) with acute coronary syndrome: study design and protocol of a prospective observational study
Q89579655	Sub-segmental quantification of single (stress)-pass perfusion CMR improves the diagnostic accuracy for detection of obstructive coronary artery disease
Q90060026	Subcategorizing the Expected Value of Perfect Implementation to Identify When and Where to Invest in Implementation Initiatives
Q92290439	Subclinical Atherosclerosis Imaging in People Living with HIV
Q89220331	Subjective Global Assessment-Dialysis Malnutrition Score and cardiovascular risk in hemodialysis patients: an observational cohort study
Q40980149	Successful percutaneous coronary intervention in the setting of an aberrant left coronary artery arising from the right coronary cusp in a patient with acute coronary syndrome: a case report.
Q62503595	Superior Risk Stratification With Coronary Computed Tomography Angiography Using a Comprehensive Atherosclerotic Risk Score
Q46244106	Supplemental oxygen therapy does not affect the systemic inflammatory response to acute myocardial infarction
Q42354882	Surgery after drug-eluting stent implantation: it's not all doom and gloom!
Q33646807	Switching between ticagrelor and clopidogrel in patients who underwent percutaneous coronary intervention: insight into contemporary practice in Chinese patients
Q36619562	Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis
Q38761351	Systematic review of cost-effectiveness of myocardial perfusion scintigraphy in patients with ischaemic heart disease: A report from the cardiovascular committee of the European Association of Nuclear Medicine. Endorsed by the European Association o
Q38824526	Systematic review of the clinical impact of dual antiplatelet therapy discontinuation after acute coronary syndromes
Q56342011	T1 and T2 mapping in the identification of acute myocardial injury in patients with NSTEMI
Q90614275	Takotsubo syndrome: between evidence, myths, and misunderstandings
Q38633613	Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes.
Q61446637	Temporal trends and inequalities in coronary angiography utilization in the management of non-ST-Elevation acute coronary syndromes in the U.S
Q31146916	Temporal trends and outcomes associated with atrial fibrillation observed during acute coronary syndrome: Real-world data from the Acute Coronary Syndrome Israeli Survey (ACSIS), 2000-2013.
Q38782804	Temporal trends in acute myocardial infarction presentation and association with use of cardioprotective drugs: A nationwide registry-based study
Q92482975	The 'de Winter' electrocardiogram pattern as a ST-elevation myocardial infarction equivalent: a case report
Q41270598	The ACEF (age, creatinine, ejection fraction) score predicts ischemic and bleeding outcomes of patients with acute coronary syndromes treated conservatively
Q90044778	The Alzheimer's Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease: JACC Focus Seminar
Q89521220	The Biomarkers for Acute Myocardial Infarction and Heart Failure
Q37595232	The Differential Diagnosis of Dyspnea
Q59807214	The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study
Q58696046	The Effects of Geography on Outcomes of Routine Early Versus Selective Late Revascularization Strategy in the Treatment of Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Transatlantic Randomized Controlled Tria
Q39469443	The Emergency Medical Care of Patients With Acute Myocardial Infarction
Q94672385	The GRACE Scale in the Prognosis of Patients with Takotsubo Syndrome
Q40000336	The Impact of CYP2C19 Loss-of-Function Polymorphisms, Clinical, and Demographic Variables on Platelet Response to Clopidogrel Evaluated Using Impedance Aggregometry
Q97645493	The Impact of Coexistence of Smoking and Diabetes on the Coronary Artery Severity and Outcomes following Percutaneous Coronary Intervention: Results from the 1ST Jordanian PCI Registry
Q64230663	The Importance of Apneic Events in Obstructive Sleep Apnea Associated with Acute Coronary Syndrome
Q36322052	The Interdisciplinary Management of Acute Chest Pain
Q64075949	The Irreplaceable Value of Laboratory Diagnostics: Four Recent Tests that have Revolutionized Clinical Practice
Q42339373	The Management and Prognostic Factors of Acute Coronary Syndrome: Evidence from the Taiwan Acute Coronary Syndrome Full Spectrum Registry.
Q90429817	The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly
Q92484523	The Mean Platelet Volume in the Prognosis of Coronary Artery Disease Severity and Risk Stratification of Acute Coronary Syndromes
Q51593840	The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction.
Q50089457	The Prognostic Value of Lipoprotein-Associated Phospholipase A2 in the Long-Term Care of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Q37480773	The RAPID-CTCA trial (Rapid Assessment of Potential Ischaemic Heart Disease with CTCA) - a multicentre parallel-group randomised trial to compare early computerised tomography coronary angiography versus standard care in patients presenting with sus
Q57118655	The Relationship between Nesfatin-1 Levels and SYNTAX Score in Patients with Non-ST Segment Elevation Myocardial Infarction
Q39096073	The Rise and Fall of Anticoagulation with Bivalirudin During Percutaneous Coronary Interventions: A Review Article
Q91671747	The Romanian National Registry of non-ST Elevation Acute Coronary Syndromes - Design and Rationale
Q89941469	The Treatment of Arterial Hypertension
Q36882866	The Treatment of Disorders of Lipid Metabolism
Q91690326	The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
Q47103308	The Use Pattern and Clinical Impact of New Antiplatelet Agents Including Prasugrel and Ticagrelor on 30-day Outcomes after Acute Myocardial Infarction in Korea: Korean Health Insurance Review and Assessment Data
Q92574169	The Veracity of Troponin Test Requests for Patients Presenting to the Emergency Department with Chest Pain; a Clinical Audit
Q61801589	The Year in Cardiology 2018: ABC Cardiol and RPC at a glance
Q64136664	The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial
Q58114387	The association of clopidogrel and 2-oxo-clopidogrel plasma levels and the 40 months clinical outcome after primary PCI
Q51834427	The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
Q90480530	The coagulation system in atherothrombosis: Implications for new therapeutic strategies
Q38647973	The cost-utility of point-of-care troponin testing to diagnose acute coronary syndrome in primary care
Q36698261	The development and application of a high-sensitivity immunoassay for cardiac myosin-binding protein C
Q89160740	The effect of cessation of 2nd generation P2Y12 inhibitor therapy on platelet reactivity in patients 1 year after acute myocardial infarction
Q99411649	The effect of nicorandil in patients with cardiac syndrome X: A meta-analysis of randomized controlled trials
Q38599449	The effect of socioeconomic disadvantage on prescription of guideline-recommended medications for patients with acute coronary syndrome: systematic review and meta-analysis
Q92624983	The feasibility of the 1-h high-sensitivity cardiac troponin T algorithm to rule-in and rule-out acute myocardial infarction in Thai emergency patients: an observational study
Q92188704	The first survey of the Saudi Acute Myocardial Infarction Registry Program: Main results and long-term outcomes (STARS-1 Program)
Q89912295	The impact of an acute chest pain pathway on the investigation and management of cardiac chest pain
Q64065962	The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction
Q90582060	The natural history of napkin-ring sign by coronary computed tomography angiography
Q38732124	The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysis.
Q47936752	The prescription of antiplatelet medication in a very elderly population: An observational study in 15 141 ambulatory subjects.
Q38735704	The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients
Q48280475	The race for higher sensitivity troponins, but for what prize?
Q88462754	The relationship between timing of prasugrel pretreatment and in-stent thrombus immediately after percutaneous coronary intervention for acute coronary syndrome: an optical coherence tomography study
Q90241999	The role of MTHFR C677T and ALDH2 Glu504Lys polymorphism in acute coronary syndrome in a Hakka population in southern China
Q47369963	The role of oral anticoagulant therapy in patients with acute coronary syndrome
Q51551532	The search for optimal dual antiplatelet therapy after PCI: fine-tuning of initiation and duration.
Q33850936	The unique value of cardiovascular magnetic resonance in patients with suspected acute coronary syndrome and culprit-free coronary angiograms.
Q38403020	The value of predischarge exercise ECG testing in chest pain patients in the era of high-sensitivity troponins
Q50193541	The year in cardiology 2017: acute coronary syndromes
Q50193633	The year in cardiology 2017: coronary interventions
Q90679154	Therapeutic Approach to Hypertension Urgencies and Emergencies During Acute Coronary Syndrome
Q47094019	Therapeutic management and one-year outcomes in elderly patients with acute coronary syndrome
Q55484545	Thirty-day rehospitalizations among elderly patients with acute myocardial infarction: Impact of postdischarge ambulatory care.
Q31155795	Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients
Q64987954	Thromboelastography-derived parameters for the prediction of acute thromboembolism following non-steroidal anti-inflammatory drug-induced gastrointestinal bleeding: A retrospective study.
Q40525871	Thrombus aspiration in patients with acute myocardial infarction : Scientific evidence and guideline recommendations
Q64107848	Thyrocervical trunk perforation: A rare vascular complication during cardiac intervention through right radial approach: A case report and literature review
Q49337303	Ticagrelor - toward more efficient platelet inhibition and beyond.
Q40901494	Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery
Q91945913	Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel
Q38869502	Ticagrelor for the treatment of atherosclerotic disease: insights from the PARTHENON clinical development program
Q48344587	Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy
Q36240716	Ticagrelor induced systemic inflammatory response syndrome
Q38675528	Ticagrelor mitigates ischaemia-reperfusion induced vascular endothelial dysfunction in healthy young males - a randomized, single-blinded study.
Q33893920	Ticagrelor-Associated Conduction Disorder: A Case Report and Review of the Literature.
Q49908641	Ticagrelor: A Review in Long Term Secondary Prevention of Cardiovascular Events
Q94562701	Ticagrelor: A safe option as part of triple therapy?
Q28074647	Time to shift from contemporary to high-sensitivity cardiac troponin in diagnosis of acute coronary syndromes
Q38650382	Time-based measures of treatment effect: reassessment of ticagrelor and clopidogrel from the PLATO trial
Q50017162	Timing of coronary angioplasty in patients with non-ST-segment elevation acute coronary syndromes.
Q47106446	Timing of invasive strategy in patients with non-ST-segment elevation acute coronary syndrome and effect on clinical outcomes.
Q50017119	Timing of percutaneous coronary intervention in patients with non-ST-elevation myocardial infarction: a SWEDEHEART study
Q58766894	Transcutaneous Puncture of an Undeflatable Coronary Angioplasty Balloon Catheter
Q55236837	Transitioning high sensitivity cardiac troponin I (hs-cTnI) into routine diagnostic use: More than just a sensitivity issue.
Q93092190	Translation, Cultural Adaptation, and Psychometric Properties of the Danish Version of the Anti-Clot Treatment Scale
Q88195793	Transradial Approach in Primary Percutaneous Coronary Intervention: Lessons from a High-volume Centre
Q88543054	Transradial percutaneous coronary intervention for left main bifurcation lesions using 7.5-Fr sheathless guide catheter
Q26470604	Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in patients with coronary artery disease
Q57689358	Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease
Q89208228	Treating patients suffering from acute coronary syndrome with prasugrel, the Rotterdam experience
Q64104667	Treatment Outcomes of Patients with Acute Coronary Syndrome Admitted to Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
Q92482331	Treatment of severe upper gastrointestinal bleeding caused by Mallory-Weiss syndrome after primary coronary intervention for acute inferior wall myocardial infarction: A case report
Q64284601	Treatment patterns of non-ST-elevation acute coronary syndrome patients presenting at non-PCI centres in the Netherlands and possible logistical consequences of adopting same-day transfer to PCI centres: a registry-based evaluation
Q64914899	Treatment strategies and outcomes in patients with non-ST-elevation acute coronary syndrome in the Netherlands.
Q40363705	Treatments and in-hospital mortality in acute myocardial infarction patients with rheumatoid arthritis: a nationwide retrospective cohort study in Japan
Q55405283	Trends and variations in the prescribing of secondary preventative cardiovascular therapies for non-ST elevation myocardial infarction (NSTEMI) in Malaysia.
Q93066358	Trends in mass spectrometry imaging for cardiovascular diseases
Q64266897	Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study
Q89585412	Triglyceride to high-density lipoprotein cholesterol ratio as a risk factor of repeat revascularization among patients with acute coronary syndrome after first-time percutaneous coronary intervention
Q51805253	Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review.
Q89397561	Triple Therapy: When, if Ever?
Q37463805	Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention - real life assessment
Q39193524	Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a viewpoint
Q90644485	Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
Q38651349	Troponin I and T in relation to cardiac injury detected with electrocardiography in a population-based cohort - The Maastricht Study.
Q40247825	Troponin T elevation after permanent pacemaker implantation
Q50089706	Troponin measurement in patients with suspected acute coronary syndromes: walking beyond the wall
Q92616791	Troponins, Acute Coronary Syndrome and Renal Disease: From Acute Kidney Injury Through End-stage Kidney Disease
Q64097090	True 99th centile of high sensitivity cardiac troponin for hospital patients: prospective, observational cohort study
Q91899235	Turkish Society of Cardiology consensus paper on the rational use of cardiac troponins in daily practice
Q48518783	Two-dimensional speckle-tracking global longitudinal strain in high-sensitivity troponin-negative low-risk patients with unstable angina: a "resting ischemia test"?
Q38837406	Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome
Q26772996	Type 2 Diabetes and ADP Receptor Blocker Therapy
Q40473310	Undetectable Concentrations of a Food and Drug Administration-approved High-sensitivity Cardiac Troponin T Assay to Rule Out Acute Myocardial Infarction at Emergency Department Arrival.
Q64979792	Unmet Needs in Managing Myocardial Infarction in Patients With Malignancy.
Q64106057	Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease
Q90674539	Update of the Brazilian Guideline on Nuclear Cardiology - 2020
Q92684923	Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology - 2019
Q97421102	Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
Q64279647	Usage of PCI and long-term cardiovascular risk in post-myocardial infarction patients: a nationwide registry cohort study from Finland
Q48186587	Use of two-dimensional speckle tracking echocardiography to predict cardiac events: Comparison of patients with acute myocardial infarction and chronic coronary artery disease.
Q90471261	Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a 'real world' prospective registry
Q93147965	Usefulness of white blood cell count to mean platelet volume ratio in the prediction of SYNTAX score in patients with non-ST elevation myocardial infarction
Q42371899	Using Smart Technology to Improve Outcomes in Myocardial Infarction Patients: Rationale and Design of a Protocol for a Randomized Controlled Trial, The Box.
Q64966471	Using Ticagrelor to Prevent Recurrent Type 1 and Type 2 Myocardial Infarctions: Boon or Bane?
Q33788916	Utility of the History and Physical Examination in the Detection of Acute Coronary Syndromes in Emergency Department Patients.
Q90224732	Utilization and Costs of Noninvasive Cardiac Tests After Acute Coronary Syndromes: Insights From the Alberta COAPT Study
Q47772721	Validation of NICE diagnostic guidance for rule out of myocardial infarction using high-sensitivity troponin tests
Q92305993	Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction
Q58755441	Value of the fT3/fT4 ratio and its combination with the GRACE risk score in predicting the prognosis in euthyroid patients with acute myocardial infarction undergoing percutaneous coronary intervention: a prospective cohort study
Q53242322	Valvular heart disease: new risk factors and new challenges.
Q47716507	Variability and Error in Cardiac Troponin Testing: An ACLPS Critical Review
Q93066707	Variations of electrocardiographic parameters during hospitalization predict long-term outcomes in patients with non-ST-segment elevation myocardial infarction
Q90394825	Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis
Q28069720	Vascular Disease in Young Indians (20-40 years): Role of Ischemic Heart Disease
Q48197071	Vascular access site complication in transfemoral coronary angiography between uninterrupted warfarin and heparin bridging
Q48543645	Vasopressors for acute myocardial infarction complicated by cardiogenic shock
Q64272828	Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome
Q49722994	Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach
Q87618682	Wellens' syndrome
Q89181349	Wellens' syndrome: a close call
Q28072343	When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?
Q54270585	Who needs secondary prevention?
Q38851769	Why we need intravenous antiplatelet agents
Q89288117	Women and acute kidney injury in myocardial infarction
Q52836688	[Acute chest pain].
Q88991681	[Cardiac causes of chest pain]
Q87981965	[Cardiac support and replacement systems]
Q88090364	[Coronary interventions : Current developments for improved long-term results]
Q52982475	[Diamond-Forrester and cardiac CT : Is there a need to redefine the pretest probability of coronary artery disease?].
Q86643067	[ESC guidelines 2015. Non-ST-elevation acute coronary syndrome]
Q58129424	[Efficacy of combined ultrasound and microbubble treatment for thrombolysis for rescuing ischemic tissues in rats at different time after thrombosis]
Q53726267	[Emergency treatment of tachycardias].
Q89184276	[Essential cardiac biomarkers in the differential diagnosis of acute chest pain : An update]
Q88551227	[Infarct-related cardiogenic shock : Prognosis and treatment]
Q57453306	[MINOCA-myocardial infarction with non-obstructive coronary arteries]
Q50875552	[Management of acute coronary syndrome without ST-segment elevation].
Q88196920	[Management of a massive cervical hematoma after insertion of a central venous catheter under tirofiban]
Q53535820	[Non-vitamin K dependent oral anticoagulants : What is important in intensive care medicine].
Q89799719	[Novel cancer treatment and the cardiovascular risk : What should cardiologists know?]
Q88533663	[Oxygen therapy in acute myocardial infarction]
Q89623293	[Platelet inhibition in elderly patients]
Q52981853	[Recommendations of the ESC guidelines regarding cardiovascular imaging].
Q52857931	[Role of coronary intervention after successful cardiopulmonary resuscitation].
Q54786249	[Secondary prevention with antiplatelet therapy in cardiac rehabilitation].
Q88266811	[The heart team in planning and performance of revascularization : ESC guidelines versus clinical routine]
Q53536784	[Vitamin K antagonists : Is their prescription really "medical malpractice" today?]
Q57793662	e-Transmission of ECGs for expert consultation results in improved triage and treatment of patients with acute ischaemic chest pain by ambulance paramedics
Q89689960	β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease
Q49234909	β-Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In-Hospital and 12-Month Outcome: Results From the GULF-RACE 2 (Gulf Registry of Acute Coronary Events-2).
Q33758547	β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.
Q91782163	β-blockers after myocardial infarction and 1-year clinical outcome - a retrospective study
Q88983094	Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018

P356	DOI	10.1093/EURHEARTJ/EHV320
P8608	Fatcat ID	release_234fc4ygnrcgxp6kwk7jn5bw2a
P698	PubMed publication ID	26320110
P5875	ResearchGate publication ID	281363724

P50	author	Philippe Gabriel Steg	Q16027739
		Ulf Landmesser	Q27235435
		Jean-Philippe Collet	Q28468999
		Debabrata Mukherjee	Q37375046
		Jeroen Joost Bax	Q77085900
		Derek P Chew	Q79135799
		Udo Sechtem	Q84837366
		Stefan James	Q86735199
		Felicita Andreotti	Q89285015
		Thomas Cuisset	Q90784770
		Carlos Brotons	Q91470497
		Carlo Patrono	Q93053731
		Filip Casselman	Q95331073
		Marco Roffi	Q103809301
		José Luis Zamorano	Q114244147
		Helmut Baumgartner	Q114244150
		Keld Per Kjeldsen	Q114403006
		Oliver Gaemperli	Q114409749
		Stefan Agewall	Q114420238
		Efstathios K Iliodromitis	Q114430033
		Lina Badimon	Q38545654
		Robert F. Storey	Q38590637
		Scipione Carerj	Q41774960
		Julinda Mehilli	Q43249625
		Marco Valgimigli	Q44964242
		Héctor Bueno	Q56435517
		Michael A. Borger	Q56475856
		Donna Fitzsimons	Q57052635
		Dimitrios Richter	Q57486110
		Gregory Lip	Q60393087
		Baris Gencer	Q61164053
		Gerd Hasenfuss	Q61457522
		Patrizio Lancellotti	Q61863551
		Stephan Achenbach	Q63168606
		Stephan Windecker	Q63256285
		Christiaan Vrints	Q66764574
		Christian W Hamm	Q66829316
P2093	author name string	Colin Baigent
		Thomas Rosemann
		Kurt Huber
		Massimo F Piepoli
		Basil S Lewis
		Raffaele Bugiardini
		Christian Mueller
		Martin Halle
		David Hildick-Smith
		Çetin Erol
		Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology
P433	issue	3
P921	main subject	patient	Q181600
		acute coronary syndrome	Q266018
P1104	number of pages	49
P304	page(s)	267-315
P577	publication date	2015-08-29
P1433	published in	European Heart Journal	Q2286839
P1476	title	2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati
P478	volume	37

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

scientific article published on 29 August 2015

Reverse relations